Medicine and Dentistry
Prostate Cancer
50%
Biopsy Technique
47%
Malignant Neoplasm
33%
Urologic Surgery
33%
Thromboembolism
33%
Prospective Study
33%
Overactive Bladder
33%
Biological Marker
33%
Bladder Dysfunction
33%
Needle Biopsy
33%
Infection
33%
Extracorporeal Shockwave Therapy
33%
International Index of Erectile Function
33%
Erectile Dysfunction
33%
Prostatectomy
33%
Pulse Generator
27%
Prostate Biopsy
26%
Sham Procedure
25%
Rectum Mucosa
16%
Antibiotic Resistance
16%
Cystectomy
13%
Kidney Surgery
13%
Transurethral Resection
9%
Maintenance Therapy
8%
Outpatient
8%
Nocturia
8%
Treatment Effect
8%
Treatment Group
8%
Surgical Technique
6%
Health Care Cost
6%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Prostate Cancer
100%
Overactive Bladder
33%
Bladder Dysfunction
33%
Gamma Chemokine
33%
Thromboembolism
33%
Malignant Neoplasm
33%
Prospective Study
33%
Multiple Sclerosis
33%
Treatment Group
33%
Lower Urinary Tract Symptom
33%
Disease Exacerbation
23%
Randomized Controlled Trial
22%
Adverse Event
11%
Nocturia
8%
Polypeptide
8%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Prospective Study
33%
Chemokine
33%
Electronic Health Record
33%
Messenger RNA
25%
Prostate-Specific Antigen
16%
Cancer Grading
16%
Urine Sampling
16%
Gleason Score
16%
Blood Level
16%
Short Term Memory
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Gene Expression Level
8%
